Global SARMs Legality Guide
Are SARMs legal? There is no single worldwide answer. Selling, importing, possessing and conducting authorised research are different activities, and the exact substance, presentation and intended purpose matter. A product being available online does not establish permission to buy or import it.
Source review: 14 October 2026. This hub summarises the specific official guidance linked below. It is general information, not legal advice or a legal clearance for any NutriMax product or transaction. Obtain advice from the relevant regulator or a qualified local adviser where the position is uncertain.
Read the question correctly
- Medicines authorisation: whether a product may be marketed as a medicine is distinct from controlled-drug classification.
- Sale, possession and import: permission for one activity does not imply permission for another. Commercial research procurement may require licences or other authority.
- Research labelling: “for research purposes only” is not a blanket exemption from medicines, customs or other applicable laws.
- Compound identity: products sold alongside SARMs are not necessarily SARMs. Peptides, NAD+ and other related compounds require their own assessment.
Official-source country summaries
United Kingdom
The MHRA assesses medicinal status using a product's claims, pharmacological properties, intended purpose and overall presentation. That includes websites and social media. This is not a basis for calling all SARMs “controlled substances” or declaring every research-labelled product lawful. A product-specific assessment is needed.
Official source: MHRA borderline-products guidance · UK guide
United States
The FDA states that SARMs are unapproved drugs and cannot legally be marketed in the US as dietary supplements or drugs. Its warning also addresses products labelled for research. This concerns marketing and authorisation; it should not be rewritten as a blanket federal controlled-substance or possession ruling.
Official source: FDA SARMs warning · US guide
Canada
Health Canada states that SARMs have not been authorised for any medical use. Its guidance warns that unauthorised health products may be refused entry or seized when import requirements are not met. This does not establish a general research-supply exemption or a blanket controlled-substance classification.
Official source: Health Canada · Canada guide
Australia
The TGA describes SARMs as experimental prescription-only medicines. Its guidance states that access requires a valid prescription, licence or authority, and import requires a permit. Research-only wording does not remove these requirements; the relevant authorisation must be established for the proposed activity.
Official source: TGA SARMs guidance · Australia guide
New Zealand
Medsafe's May 2026 advisory states that many peptide products and SARMs are prescription medicines and that importing, supplying, possessing or procuring prescription medicines requires authorisation. It explicitly rejects research-only labels as permission for sale, supply or use in people.
Official source: Medsafe advisory, 21 May 2026 · New Zealand guide
Norway
Norway must be assessed using Norwegian rules, not described as an EU member state. DMP states that SARMs are medicinal products and are not permitted for private import by post. Separate rules apply to authorised business activity. A September 2026 DMP update also added several named peptides and ibutamoren to Norway's doping list; those compounds should not be assumed to share a single SARMs classification.
Official source: DMP private-import guidance · DMP update, 15 September 2026 · Norway guide
Other countries and existing guide directory
The directory below retains our country resources. Inclusion is not confirmation of legal status or delivery availability. Countries without an official-source summary above have not been verified as part of this hub review. We do not classify them as “permitted for research”, “tolerated”, “partially regulated” or “banned” without evidence for the exact jurisdiction and activity. The linked articles have their own scope and review dates; consult current local medicines and customs authorities before relying on them.
North America
Europe
UK · Germany · France · Spain · Italy · Belgium · Sweden · Norway · Finland · Denmark · Poland · Austria · Switzerland · Portugal · Ireland · Greece · Hungary · Romania · Bulgaria · Croatia · Slovenia · Serbia · Bosnia And Herzegovina · North Macedonia · Montenegro · Albania · Kosovo · Czech Republic · Netherlands
Oceania
Australia · New Zealand · Papua New Guinea · Fiji · Solomon Islands · Vanuatu · New Caledonia · French Polynesia · Guam · Samoa · Tonga · Palau · Kiribati · Tuvalu · Nauru · Micronesia · Marshall Islands
Asia and related country resources
Turkey · Cyprus · Israel · Saudi Arabia · Qatar · Kuwait · Bahrain · Oman · Yemen · Jordan · Lebanon · Syria · Iraq · Iran · Afghanistan · Pakistan · India · Nepal · Bhutan · Bangladesh · Sri Lanka · Maldives · Thailand · Vietnam · Cambodia · Laos · Myanmar · Malaysia · Singapore · Brunei · Indonesia · East Timor Timor Leste · Philippines · United Arab Emirates
Before a research purchase or shipment
Establish the exact compound and formulation, the destination's classification, the rules for the proposed activity, and any required authority or import permit. Where these cannot be established, seek clarification before proceeding. A supplier's location, checkout availability or research disclaimer is not evidence that an international transaction is permitted.
Related regulatory resources
Supplied for research purposes only. NutriMax PES products are not intended for human or veterinary use or consumption. This statement describes the intended supply boundary; it does not override applicable law. No administration or personal-use guidance is provided.